搜索临床试验以:BRCA1 mutation
总计3369个结果
-
Translational Research Center for Medical Innovation...Okayama University; Japanese Gynecologic Oncology Group (JGOG)招聘中
-
Abramson Cancer Center at Penn Medicine主动,不招人晚期乳腺癌 | 转移性乳腺癌 | BRCA1突变 | BRCA2突变 | 局部晚期乳腺癌美国
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.主动,不招人
-
University Medical Center Nijmegen主动,不招人
-
Sheba Medical Center完全的
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)完全的
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.主动,不招人乳腺癌转移 | BRCA 1 基因突变 | BRCA 2基因突变意大利, 西班牙, 美国, 捷克语, 罗马尼亚, 法国, 大韩民国, 英国, 匈牙利, 日本, 秘鲁, 波兰, 俄罗斯联邦, 火鸡, 中国, 台湾, 保加利亚, 瑞士, 墨西哥
-
European Organisation for Research and Treatment...AstraZeneca撤销BRCA1突变 | BRCA2突变 | TNBC - 三阴性乳腺癌
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的浸润性乳腺癌 | HER2/Neu 阴性 | 乳腺癌 | 有害的 BRCA1 基因突变 | 有害的 BRCA2 基因突变美国
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan Ismail招聘中
-
Stanford UniversitySusan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation招聘中
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.完全的
-
Seoul National University HospitalBayer; Korean Society of Breast Imaging & Korean Society For Breast Screening未知
-
University Health Network, Toronto暂停
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)完全的
-
The Cleveland ClinicNational Cancer Institute (NCI)完全的乳腺癌 | 遗传性乳腺癌/卵巢癌(brca1、brca2)
-
Dana-Farber Cancer InstituteMedical University of South Carolina; National Cancer Institute (NCI); Massachusetts General Hospital 和其他合作者完全的
-
Baystate Medical Center完全的
-
Institute of Cancer Research, United KingdomCancer Research UK; National Institute for Health Research, United Kingdom招聘中
-
AstraZeneca完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...招聘中
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.未知
-
Danish Breast Cancer Cooperative Group未知
-
AstraZeneca主动,不招人
-
Australia New Zealand Gynaecological Oncology GroupBeiGene撤销
-
Severance HospitalSamsung Medical Center; Asan Medical Center; Kyungpook National University Chilgok Hospital招聘中
-
Severance HospitalSamsung Medical Center; Changhua Christian Hospital; European Institute of Oncology完全的
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.尚未招聘BRCA1突变 | BRCA2突变 | PALB2基因突变 | 激素受体阳性 HER-2 阴性乳腺癌 | 晚期或转移性乳腺癌德国
-
Hellenic Cooperative Oncology Group主动,不招人
-
Rana McKay, MDUniversity of California, San Diego; AstraZeneca招聘中前列腺癌 | BRCA1突变 | BRCA2突变 | 前列腺癌 | 高危癌症美国
-
Kari WisinskiPfizer; Celcuity Inc主动,不招人
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research Consortium招聘中乳腺癌 | I期乳腺癌 | II期乳腺癌 | HER2 阴性乳腺癌 | III期乳腺癌 | 有害的 PALB2 基因突变 | 种系 BRCA1 基因突变 | 种系 BRCA2 基因突变美国
-
Hadassah Medical Organization未知